Müller HD - Search Results

1

Autoreactive antibodies and loss of retinal ganglion cells in rats induced by immunization with ocular antigens.

Laspas P, Gramlich OW, Müller HD, Cuny CS, Gottschling PF, Pfeiffer N, Dick HB, Joachim SC, Grus FH. Laspas P, et al. Among authors: muller hd. Invest Ophthalmol Vis Sci. 2011 Nov 11;52(12):8835-48. doi: 10.1167/iovs.10-6889. Invest Ophthalmol Vis Sci. 2011. PMID: 22003114

2

Effects of early postfiltration ocular hypotony on visual acuity, long-term intraocular pressure control, and posterior segment morphology.

Schwenn O, Kersten I, Dick HB, Müller H, Pfeiffer N. Schwenn O, et al. J Glaucoma. 2001 Apr;10(2):85-8. doi: 10.1097/00061198-200104000-00003. J Glaucoma. 2001. PMID: 11316101

3

Storage diseases: diagnostic position.

Goebel HH, Müller HD. Goebel HH, et al. Among authors: muller hd. Ultrastruct Pathol. 2013 Feb;37(1):19-22. doi: 10.3109/01913123.2012.670060. Ultrastruct Pathol. 2013. PMID: 23383614 Review.

4

Protein aggregate myopathies.

Goebel HH, Müller HD. Goebel HH, et al. Among authors: muller hd. Semin Pediatr Neurol. 2006 Jun;13(2):96-103. doi: 10.1016/j.spen.2006.06.005. Semin Pediatr Neurol. 2006. PMID: 17027859 Review.

5

Macrophagic myofasciitis plus (distinct types of muscular dystrophy).

Müller HD, Landeghem FK, Schmidt PF, Sommer C, Goebel HH. Müller HD, et al. Neuropediatrics. 2009 Aug;40(4):174-8. doi: 10.1055/s-0029-1243172. Epub 2010 Feb 4. Neuropediatrics. 2009. PMID: 20135575

6

[Congenital and other myopathies].

Goebel HH, Müller HD, Schröder R. Goebel HH, et al. Among authors: muller hd. Pathologe. 2009 Sep;30(5):365-9. doi: 10.1007/s00292-009-1169-5. Pathologe. 2009. PMID: 19641920 Review. German.

7

Myocardial Fibrosis in Diabetic Cardiomyopathy: Mechanisms, Implications, and Therapeutic Perspectives.

Schmidt CE, Müller HD. Schmidt CE, et al. Among authors: muller hd. Curr Probl Cardiol. 2024 Dec 18:102976. doi: 10.1016/j.cpcardiol.2024.102976. Online ahead of print. Curr Probl Cardiol. 2024. PMID: 39706391 Review.

8

Safety and Clinical Evaluation of Dual Inhibition with Pertuzumab and Trastuzumab Biosimilar SB3 in HER2-Positive Breast Cancer Patients.

Suppan C, Steiner D, Klocker EV, Posch F, Henzinger E, Müller HD, Stöger H, Dandachi N, Balic M. Suppan C, et al. Among authors: muller hd. Breast Care (Basel). 2021 Dec;16(6):607-613. doi: 10.1159/000513766. Epub 2021 Feb 10. Breast Care (Basel). 2021. PMID: 35082570 Free PMC article.

9

Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR⁺ breast cancer patients undergoing CDK4/6 treatment.

Dandachi N, Posch F, Graf R, Suppan C, Klocker EV, Müller HD, Lindenmann J, Terbuch A, Heitzer E, Balic M. Dandachi N, et al. Among authors: muller hd. Mol Oncol. 2021 Sep;15(9):2390-2400. doi: 10.1002/1878-0261.12870. Epub 2020 Dec 18. Mol Oncol. 2021. PMID: 33264486 Free PMC article.

10

Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy.

Müller HD, Posch F, Suppan C, Bargfrieder U, Gumpoldsberger M, Hammer R, Hauser H, Dandachi N, Prein K, Stoeger H, Lax S, Balic M. Müller HD, et al. Ann Surg Oncol. 2019 Dec;26(13):4274-4283. doi: 10.1245/s10434-019-07741-w. Epub 2019 Aug 26. Ann Surg Oncol. 2019. PMID: 31452052 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters